Toxicity vs tumour control: What makes a good pelvic radiotherapy plan?

Sunday

May 08

10:30 - 11:30

Auditorium 12

Tumour radiobiology

Co-Chair: Daan Boreel, The Netherlands;

Chair: Kasper Rouschop, The Netherlands

Overview: Proffered Papers are presented at one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be streamed.

Session Code: 2210

Session Type: Proffered Papers

Track: Radiobiology

10:30 - 10:40

Avoidance of DNA Replication Stress Leads to Decreased Cytosolic DNA in Breast Cancer Stem Cells

Kerstin Borgmann, Germany

Presentation Number: OC-0425

10:40 - 10:50

ALDH genes as regulators of prostate cancer radioresistance, stemness and bone metastases

Ielizaveta Gorodetska, Germany

Presentation Number: OC-0426

10:50 - 11:00

Interplay of cancer stemness and amino acid transporters regulates radioresistance in HNSCC

Ayşe Sedef Köseer, Germany

Presentation Number: OC-0427

11:00 - 11:10

Development of DNA polymerase theta inhibitors as tumour specific radiosensitisers

Geoff Higgins, United Kingdom

Presentation Number: OC-0428

11:10 - 11:20

Tamoxifen induces metabolic adaptations leading to radioresistance in breast cancer

Flavia Naumann, The Netherlands

Presentation Number: OC-0429

11:20 - 11:30

Multi-candidate immunohistochemical assessment of prognostic biomarkers in the CHHiP prostate trial.

Anna Wilkins, United Kingdom

Presentation Number: OC-0430

ESTRO 2022

Session